Skip to Content

Notice

Notice of Intent To Grant Exclusive Patent License; American BioHealth Group, LLC

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Department of the Navy, DOD

ACTION:

Notice.

SUMMARY:

The Department of the Navy hereby gives notice of its intent to grant to American BioHealth Group, LLC, a revocable, nonassignable, exclusive license in the United States to practice, with right to sublicense, the Government-owned invention described in U.S. Patent Application Serial No. 09/766, 625, entitled “Prevention or Reversal of Sensorial Hearing Loss Through Biological Mechanisms,” filed January 23, 2001.

DATES:

Anyone wishing to object to the granting of this license has (15) days from the date of this notice to file written objections along with supporting evidence, if any.

ADDRESSES:

Written objections are to be filed with the Office of Technology Transfer, Naval Medical Research Center, 503 Robert Grant Ave, Silver Spring, MD 20910-7500.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Dr. Charles Schlagel, Director, Office of Technology Transfer, Naval Medical Research Center, 503 Robert Grant Ave, Silver Spring, MD 20910-7500, telephone (301) 319-7428, fax (301) 319-7432, or E-Mail: schlagelc@nmrc.navy.mil.

Start Signature

Dated: March 14, 2003.

R. E. Vincent II,

Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy, Federal Register Liaison Officer.

End Signature End Further Info End Preamble

[FR Doc. 03-7351 Filed 3-26-03; 8:45 am]

BILLING CODE 3810-FF-M